Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
6.01
+0.16 (2.74%)
At close: Jun 26, 2026, 4:00 PM EDT
5.96
-0.05 (-0.86%)
After-hours: Jun 26, 2026, 7:39 PM EDT
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 533 employees as of December 31, 2025. The number of employees increased by 165 or 44.84% compared to the previous year.
Employees
533
Change (1Y)
165
Growth (1Y)
44.84%
Revenue / Employee
$408,597
Profits / Employee
-$449,432
Market Cap
361.41M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Rocket Pharmaceuticals | 202 |
| OmniAb | 89 |
| Upstream Bio | 75 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 59 |
| Atea Pharmaceuticals | 55 |
| X4 Pharmaceuticals | 45 |
| Compass Therapeutics | 39 |
VNDA News
- 24 days ago - Vanda Pharmaceuticals Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Vanda Pharmaceuticals’ imsidolimab granted orphan drug designation in Japan - TheFly
- 4 weeks ago - Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis - PRNewsWire
- 5 weeks ago - Vanda Pharmaceuticals Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 5 weeks ago - Vanda Pharmaceuticals Slides: Corporate presentation - Filings
- 6 weeks ago - Vanda Pharmaceuticals price target lowered to $21 from $24 at H.C. Wainwright - TheFly
- 7 weeks ago - Vanda Pharmaceuticals Announces Participation at May 2026 Investor Conferences - PRNewsWire
- 7 weeks ago - Vanda Pharmaceuticals reports Q1 EPS (82c) vs. (50c) last year - TheFly